Chopra Karan, Singh Devinder, Hricz Nick, Brassard Kylie, Orlov Virginia, Holton Iii Luther H
Division of Plastic Surgery, Anne Arundel Medical Center, Annapolis, Md.
Plast Reconstr Surg Glob Open. 2019 Mar 25;7(3):e2051. doi: 10.1097/GOX.0000000000002051. eCollection 2019 Mar.
The AeroForm tissue expander is a carbon dioxide-filled breast tissue expander that allows gradual, needle-free expansion using a hand-held remote controller. This study evaluates 2-stage, prepectoral tissue expander-to-implant breast reconstruction with the carbon-dioxide tissue expanders and compares the outcomes to our recent experience with saline tissue expanders.
This was a retrospective study of consecutive patients from a single institution. The subjects consisted of women who underwent mastectomy and either immediate or delayed breast reconstruction with AeroForm or saline tissue expanders. Outcomes encompassed postoperative complications including mastectomy flap necrosis, infection requiring readmission and/or intravenous antibiotics, capsular contracture, hematoma, seroma, skin dehiscence, extrusion, premature explant, and loss of communication with the device (AeroForm) or rupture of the device (saline).
This study evaluated 115 patients with 185 breast reconstructions. Of the 185 breast reconstructions, 74 (40%) utilized AeroForm tissue expanders and 111 (60%) utilized traditional saline tissue expanders. Treatment was successful in 100% and 94% in the AeroForm and saline groups, respectively ( = 0.025). The incidence of adverse events was greater in the saline group (45.9% versus 32.4%). Surgical-site infection occurred more commonly in the saline group (5.4% versus 0%). Full-thickness skin necrosis occurred at a significantly higher rate in the saline cohort as compared with AeroForm (5.4% versus 0%).
The use of AeroForm tissue expanders offers notable advantages for breast reconstruction. This device when employed in the prepectoral space may be associated with reduced infection rates and decreased utilization of healthcare and patient resources.
AeroForm组织扩张器是一种充有二氧化碳的乳房组织扩张器,可使用手持遥控器进行逐步、无针扩张。本研究评估了使用二氧化碳组织扩张器进行两阶段、胸肌前组织扩张器至植入物的乳房重建,并将结果与我们最近使用盐水组织扩张器的经验进行比较。
这是一项对来自单一机构的连续患者的回顾性研究。研究对象包括接受乳房切除术并使用AeroForm或盐水组织扩张器进行即刻或延迟乳房重建的女性。结果包括术后并发症,如乳房切除皮瓣坏死、需要再次入院和/或静脉使用抗生素的感染、包膜挛缩、血肿、血清肿、皮肤裂开、挤出、过早取出植入物以及与装置失去连通(AeroForm)或装置破裂(盐水)。
本研究评估了115例患者的185次乳房重建。在185次乳房重建中,74例(40%)使用了AeroForm组织扩张器,111例(60%)使用了传统盐水组织扩张器。AeroForm组和盐水组的治疗成功率分别为100%和94%(P = 0.025)。盐水组不良事件的发生率更高(45.9%对32.4%)。手术部位感染在盐水组中更常见(5.4%对0%)。与AeroForm相比,盐水组全层皮肤坏死的发生率显著更高(5.4%对0%)。
使用AeroForm组织扩张器进行乳房重建具有显著优势。该装置用于胸肌前间隙时,可能会降低感染率,并减少医疗保健和患者资源的利用。